Our partner is a clinical-stage biopharmaceutical company that is focused on the development of innovative therapeutics designed to significantly improve outcomes for patients with liver disease.

This MD, Ph.D has over 20 years of industry experience(pharma and biotech) in R&D across a breadth of therapeutic categories, including liver disease, endocrinology, rare disease, autoimmune, gastrointestinal and infectious disease. They have a proven track record in leading high-performing teams and delivering on complex programs, with deep experience in bringing products from first-in-human studies through to approval. This hire oversaw clinical development efforts for our partner’s portfolio programs and helped set the overall development strategy for the company.